Open Heart

JUNE 24, 2022

Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. A pilot study ‘COVID-19 blood pressure endothelium interaction study’, which found that patients with normal blood pressure (BP) at the time of hospital admission with COVID-19 showed an 8.6 mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19.

Blood Pressure 52

Blood Pressure COVID-19 Myocardial Infarction Hypertension 52

EMS 12-Lead

JUNE 20, 2022

David Didlake Firefighter / Paramedic Acute Care Nurse Practitioner @DidlakeDW Peer review provided by Dr. Steve Smith @SmithECGblog I was conducting QA/QI on two very recent cases and was struck by the uniqueness of both. CASE 1 A 45 y/o Male called 911 for new onset central chest discomfort, non-radiating, 5/10 pain scale, and without any vomiting, diaphoresis, or pallor.

STEMI 52

STEMI Stent Stents Myocardial Infarction 52

ECG Cases

JUNE 21, 2022

In this ECG Cases blog we review 8 cases of patients with prehospital ECGs and explore prehospital ECGs for diagnosing STEMI, Occlusion MI, false STEMI, code STEMI, dynamic ischemic changes, truncated voltages. Can you avoid the pitfalls and spot the pearls that help to make the diagnosis? The post ECG Cases 32 Prehospital ECG pearls and pitfalls appeared first on Emergency Medicine Cases.

STEMI 52

STEMI Blog 52

Dr. Wes

JUNE 20, 2022

Recently, there have been a rash of initiatives by unaccountable non-profit physician credentialing organizations (Federation of State Medical Boards, the American Boards of Internal Medicine, Family Medicine and Pediatrics), and the American Medical Association to come to the public's rescue by de-credentialing U.S.

COVID-19 52

COVID-19 Pediatrics Certification 52

Open Heart

JUNE 24, 2022

Objective Short-term ambient fine particulate matter (PM 2.5 ) is associated with adverse cardiovascular events including myocardial infarction (MI). However, few studies have examined associations between PM 2.5 and subclinical cardiomyocyte damage outside of overt cardiovascular events. Here we evaluate the impact of daily PM 2.5 on cardiac troponin I, a cardiomyocyte specific biomarker of cellular damage.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Cardiovascular Disease 52

Open Heart

JUNE 22, 2022

Objective Congestive acute kidney injury (c-AKI) refers to AKI in the presence of right ventricular failure (RVF) and is a highly morbid complication of cardiac surgery. However, treatment has traditionally been reactive rather than proactive due to limited modalities to predict this complication. The objective of this study was to investigate the ability of insulin-like growth-factor binding protein 7 (IGFBP7), to predict c-AKI, AKI and RVF in patients undergoing cardiac surgery, as compared to

Biomarkers 52

Biomarkers Pulmonary Outcomes 52

Open Heart

JUNE 21, 2022

Background Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression. We thus compared AS progression after an acute MI and in patients with/without history of MI, and assessed post-MI pathobiological changes within the aortic valve leaflets in a sheep model.

Myocardial Infarction 52

Myocardial Infarction Aortic Aortic valve Stenosis 52

Open Heart

JUNE 21, 2022

Background Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial. Objective The aim of this systematic review and meta-analysis was to assess the effect of timing of complete revascularisation on cardiovascular outcomes in patients with STEMI and multivessel coronary a

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Artery Disease Outcomes 52

ECG Cases

JUNE 21, 2022

In this month's EM Quick Hits podcast Justin Morgenstern & Eddy Lang discuss the problem of overdiagnosis in EM, Anand Swaminathan's approach to indications and dosing of thrombolytics for submassive (intermediate risk) pulmonary embolism, Tahara Bhate's QI Corner on a patient with unexplained shortness of breath, Brit Long on emergency treatment of the bleeding hemophilia patient.

Embolism 52

Embolism Pulmonary 52